print

Country Report

Uruguay Flag Analgesics in Uruguay

| Pages: 27

Price: US$990

About this Report

Executive Summary

TRENDS

  • Analgesics is one of the categories with the highest consumption increase amongst Uruguayan population due to the self-medication growth. In Uruguay, self-medication is a growing concern amongst the sectors involved in the health field. There are many OTC medications, but authorities are concerned mainly about self-medication by psychotropic drugs, narcotics and tranquilisers (eg benzodiazepine). The second concern is the consumption of analgesics and anti-inflammatories and and the third concern is the antibiotics consumption. The sustained consumer demand for OTC analgesics can be explained by the well-established demand for these products and the general public confidence in analgesics amongst the population of Uruguay. Uruguay ranks amongst the top countries in Latin America in per capita consumer expenditure on analgesics, surpassed only by Peru, Costa Rica, Brazil and Venezuela measured in value terms.

COMPETITIVE LANDSCAPE

  • Gramon Bagó de Uruguay SA is expected to continue leading analgesics sales in 2015, with 33% value share, followed by Bayer SA Uruguay with 13% value share. Gramon Bagó’s overwhelming success is the major reason for the popularity of its Dolanet brand, which is now available in the Dolanet Comprimidos and Dolanet Jarabe variants. The strong demand for these products continues sustaining the company’s leadership in acetaminophen. Furthermore, this product is compatible with any other anti-inflammatory medicines.

PROSPECTS

  • Analgesics development will be closely related to the evolution of the economy as well as with the main actions to control self-medication amongst the population. It is expected that increasing inflation would have a negative effect on analgesics growth.

GET MORE FOR LESS!


For orders of 3 or more reports, in addition to your multi-purchase discount, we will provide any strategy or global briefing absolutely free.

Please contact a web site agent using the chat box or complete the form here to receive your free strategic briefing. 



Samples (FAQs about samples):

doc_pdf.pngSample Analgesics Market Research Report

doc_excel_table.pngSample Analgesics Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Uruguay with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Uruguay, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Uruguay market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Uruguay?
  • What are the major brands in Uruguay?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Analgesics in Uruguay - Category Analysis

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 1 Sales of Analgesics by Category: Value 2010-2015
  • Table 2 Sales of Analgesics by Category: % Value Growth 2010-2015
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2010-2015
  • Table 4 NBO Company Shares of Analgesics: % Value 2011-2015
  • Table 5 LBN Brand Shares of Analgesics: % Value 2012-2015
  • Table 6 Forecast Sales of Analgesics by Category: Value 2015-2020
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2015-2020

Analgesics in Uruguay - Company Profiles

Gramon Bagó de Uruguay SA in Consumer Health (Uruguay)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 1 Gramon Bagó de Uruguay SA: Key Facts
  • Summary 2 Gramon Bagó de Uruguay SA: Operational Indicators

COMPETITIVE POSITIONING

  • Summary 3 Gramon Bagó de Uruguay SA: Competitive Position 2015

Spefar SA in Consumer Health (Uruguay)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 4 Spefar SA: Key Facts
  • Summary 5 Spefar SA: Operational Indicators

COMPETITIVE POSITIONING

  • Summary 6 Spefar SA: Competitive Position 2015

Consumer Health in Uruguay - Industry Context

EXECUTIVE SUMMARY

Slight growth of consumer health

Dermatologicals continues leading the growth in OTC consumer health

Delay of marijuana sales at chemists/pharmacies

Multinational leadership with no domestic production

Expectations remain negative in the short term

KEY TRENDS AND DEVELOPMENTS

Actions against consumer self-medication

Chemists/pharmacies: One of the marijuana sales channels

Measures that drive the Uruguayan pharmaceutical industry

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
  • Table 9 Life Expectancy at Birth 2010-2015

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2010-2015
  • Table 12 NBO Company Shares of Consumer Health: % Value 2011-2015
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2012-2015
  • Table 14 Distribution of Consumer Health by Format: % Value 2010-2015
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2015
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2015-2020
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

  • Summary 7 OTC: Switches 2012-2014

DEFINITIONS

SOURCES

  • Summary 8 Research Sources

Segmentation

This market research report includes the following:

  • Analgesics
    • Systemic Analgesics
      • Adult Analgesics
        • Adult Acetaminophen
        • Adult Aspirin
        • Adult Combination Products - Analgesics
        • Adult Diclofenac
        • Adult Dipyrone
        • Adult Ibuprofen
        • Adult Ketoprofen
        • Adult Naproxen
        • Adult OTC Triptans
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Naproxen
      • Adult and Paediatric Systemic Analgesics
        • Acetaminophen
        • Aspirin
        • Combination Products - Analgesics
        • Diclofenac
        • Dipyrone
        • Ibuprofen
        • Ketoprofen
        • Naproxen
        • OTC Triptans
    • Topical Analgesics/Anaesthetic

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Analysis by Format
  • Herbal/Traditional vs Standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

print

Recently Viewed Items more ›

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!
    Our site uses cookies to improve functionality. Continue if you are happy with this or learn how to manage cookies by clicking here